Find Research Projects

Search results

• 4-H Community-Based Science

  Hanley, C. & Hanley, C.

  KY Department of Military Affairs

  7/1/08 → 6/30/10

  Project: Research project

• 4-H Council National Mentoring (2010)

  Burks, J.

  12/1/10 → 6/30/12

  Project: Research project

• 4th Annual University of Kentucky (UK) Philosophy Summer Camp for High School Students

  Sanday, E.

  Society of Philosophers in America

  7/1/18 → 8/15/18

  Project: Research project

• 5th Ablation Workshop: Hosting proposal

  Martin, A. & Bailey, S.

  National Aeronautics and Space Administration

  1/1/12 → 12/31/12

  Project: Research project

• 5th International Lafora Epilepsy & Glycan Workshop

  Gentry, M.

  5/17/19 → 11/15/19

  Project: Research project

• 6th Annual Commonwealth Computational Summit

  Griffioen, J.

  Oak Ridge Associated Universities

  9/1/22 → 8/30/23

  Project: Research project

• 7-AVP-786-205: A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy, Safety, and Tolerability of AVP-786 (deudextromethorphan hydrobromide [d6- DM]/quinidine sulfate [Q]) for the Treatment of Neurobehavioral Di

  Lee, D.

  Avanir Pharmaceuticals

  7/10/20 → 11/30/22

  Project: Research project

• 80% by 2018 Achievement Award

  Knight, J. & Knight, J.

  American Cancer Society

  2/11/19 → 2/10/20

  Project: Research project

• 96-week Phase IV, Randomized, Double-Blind, Multicenter Study of the Safety and Efficacy of EPZICOM Versus Truvada Administered in Conjunction wiht Kaletra in Antiretroviral-Naive HIV-1 Infected Subjects

  Greenberg, R.

  GlaxoSmithKline

  10/1/05 → 4/30/12

  Project: Research project

• 9 County Adult Drug Court Evaluation (MOA 2003-056)

  HILLER, M.

  7/1/03 → 6/30/04

  Project: Research project

• 9 County Adult Drug Court Evaluation - Year 2

  Havens, J.

  KY Administrative Office of the Courts

  10/1/03 → 6/30/05

  Project: Research project

• 9 County Adult Drug Court Evaluation - Year 3

  Havens, J.

  KY Administrative Office of the Courts

  7/1/04 → 3/31/05

  Project: Research project

• A. Phillip Owens: My88 Deficiency, in Bone Marrow Derived Cells, Attenuates both AngII-Mediated Atherosclerosis and AAA

  Daugherty, A. & Owens, A.

  American Heart Association

  7/1/06 → 6/30/08

  Project: Research project

• A0081006: 12-month open-label study to evaluate the safety and tolerability of pregabalin as adjunctive therapy in pediatric subjects 1 month to 16 years of age with partial onset seizures and pediatric and adult subjects 5 to 65 years of age with primary

  Khan, G.

  Parexel International Co

  1/20/15 → 12/30/17

  Project: Research project

• A0081041: A double-blind, placebo-controlled, parallel-group, multicenter study of the efficacy and safety of Pregabalin as adjunctive therapy in children 4 -16 years of age with partial onset seizures.

  Khan, G.

  Parexel International Co

  12/24/14 → 11/30/16

  Project: Research project

• A0081105: A randomized, double-blind, placebo-controlled, parallel group, multi center trial of pregabalin as adjunctive therapy in pediatric and adult subjects with primary generalized tonic-clonic seizures

  Khan, G.

  Parexel International Co

  12/16/14 → 11/30/16

  Project: Research project

• A 104 Week, Randomized, Double-Blind, Parallel Arm, Multi-Center Phase IIIb Study Comparing the Effects of Treatment with Rosuvastatin 40 mg or Atorvastatin 80 mg on Atherosclerotic Disease Burden As Measured By Intravascular Ultrasound in Patients

  Ziada, K.

  4/2/08 → 3/31/12

  Project: Research project

• A 12-Month, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Reslizumab (3.0mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in Patients (12-75 years of age)

  Miller, B.

  Cephalon Inc

  4/26/11 → 3/31/15

  Project: Research project

• A 12-Week, double-Blind, Randomized, Placebo-Controlled, Parallel-Group Study to Assess the Safety and Efficacy of APD356 in Obese Patients

  Anderson, J. & Reynolds, L.

  7/1/05 → 10/31/06

  Project: Research project

• A 12-week, randomised, placebo-controlled, double-blind, parallel group, multi-center trial to assess the efficacy and safety of tiotropium bromide (18 #g) delivered via theHandiHaler# in patients with newly diagnosed and/or maintenance treatment na#ve C

  Mannino, D. & Diaz Guzman Zavala, E.

  2/10/12 → 2/9/13

  Project: Research project

• A 12-Week, Randomized, Double-Blind, Placebo-Controlled Study with PRN BID and Fixed, Dosing Regimens Alosetron in Female Subjects with Severe Diarrhea-Perdominant Irritable Bowel Syndrome Who Have Failed Conventional Therapy

  De Villiers, W.

  10/1/03 → 8/31/06

  Project: Research project

• A 12 Week, Randomized, Parallel, Double-Blind, Placebo-Controlled, Multicenter Study of the Safety and Efficacy of 4 Doses of PTP-112 in Patients with Type 2 Diabetes

  Reynolds, L.

  6/15/01 → 1/3/03

  Project: Research project

• A 12-Week Dose-ranging Study (TRUMPET)

  Miller, B.

  PPD Development Inc

  7/1/12 → 4/30/14

  Project: Research project

• A 12-Week Randomized, Open-Label, Active Comparator Period Followed by a 12-Week Safety Extension Period to Evaluate the Safety and Efficacy of Fesoterodine in Subjects Aged 6 to 16 Years and > 25 KG with Symptoms of Detrusor Overactivity Associated with

  Ziada, A.

  6/21/12 → 10/31/14

  Project: Research project

• A 16-Week, Randomized, Double-Blind,Placebo-Controlled, Parallel Group Two-Site Study to Investigate the Efficacy and Tolerability of 400 mg/day of Bupropion SR Compared to Placebo for the Treatment of Adolescent Obesity

  Anderson, J., EHTISHAM, A. & Reynolds, L.

  9/1/02 → 6/1/04

  Project: Research project

• A 24 Month, Multi-Center, Open-Label, Randomized, Controlled Study to Evaluate the Efficacy and Safety of Concentration-Controlled Everolimus to Eliminate or to Reduce Tacrolimus Compared to Tacrolimus in de novo Liver Transplant Recipients

  Gedaly, R. & Ranjan, D.

  Novartis (domestic)

  7/1/08 → 7/31/14

  Project: Research project

• A 24-month, Multicenter, Randomized, Open Label Non-Inferiority Study of Efficacy and Safety Comparing Concentration Controlled Certican in Two Doses (1.5 and 3.0mg/day starting doses) with Reduced Neoral versus 1.44 Myfortic with Standard Dose Neoral

  Gedaly, R. & Johnston, T.

  Novartis (domestic)

  8/25/05 → 10/31/10

  Project: Research project

• A 24-Week, Multicenter, Randomized, Double-blind, Placebo-Controlled, Add-on, Parallel-Group Study to Assess the Effect of Rasagiline on Cognition in Patients with Parkinson#s Disease

  Slevin, J.

  Inc Research Inc

  1/11/13 → 1/30/16

  Project: Research project

• A 24 Week, randomized, Double-Blind, Placebo Controlled, Milticenter Study to Evaluate the Efficacy and Safety of 18 MCG of Tiotropium Inhalation Capsules Administered by Handihaler Once-Daily Plus PRN Albuterol (Salbutamol) VS Placebo Plus PRN Albuterol

  Doherty, D.

  7/1/07 → 6/30/11

  Project: Research project

• A 24-Week Randomized, Double-Blind, Active-Controlled, Multicenter Study to Evaluate the Safety and Efficacy of Rosiglitazone When Administered to Pediatric Patients with Type 2 Diabetes Mellitus

  Thrailkill, K.

  Smith Kline Beecham

  11/1/00 → 8/31/02

  Project: Research project

• A 24-Week Randomized, Doubleblinded Multicenter Active Controlled (Pioglitazone) Study to Evaluate the Efficacy Safety and Tolerability of Tesaglitzar Therapy

  Reynolds, L., Anderson, J. & Karounos, D.

  AstraZeneca Pharmaceuticals AB

  9/27/04 → 3/31/06

  Project: Research project

• A 26-week, Randomised, Controlled, Open Label, Multicentre, Multinational Three-arm Parallel, Treat-to-Target Trial Comparing Efficacy and Safety of 2 Different Dosing Regiments of SIBA and 1 Dosing Regimen of Insulin

  Karounos, D.

  Novo Nordisk Pharmaceuticals Inc

  3/9/10 → 6/30/11

  Project: Research project

• A 26 Week, Randomized, Double-Blind, Parallel-Group-Controlled, Multi-center Study To Evaluate the Effect of Xolair(Omalizumab) on Improving the Tolerability of Specific Immunotherapy In Patients With Persistent Allergic Asthma

  Miller, B.

  Novartis (domestic)

  5/1/06 → 8/31/08

  Project: Research project

• A 26-week treatment, multicenter, randomized, double-blind, placebo-controlled, adaptive, seamless, parallel-group study to access the efficacy, safety and tolerability of two doses of indacaterol (selected from

  Doherty, D.

  9/1/07 → 8/31/09

  Project: Research project

• A 2x2 Factorial Randomized Phase III Study of Intermittent Oral Capecitabine in Combination With Intravenous Oxaliplatin (Q3W) ("XELOX") with/without Intravenous Bevacizumab (Q3W) versus Bolus and Continuous Infusion

  DeSimone, P.

  5/1/03 → 3/31/07

  Project: Research project

• A35-003: A Compassionate Use Protocol of AMX0035 for treatment of patients with Amyotrophic Lateral Sclerosis (ALS)

  Kasarskis, E.

  United Biosource Corp

  11/11/20 → 8/14/21

  Project: Research project

• A3921086 - An Open-Label Extension Study of CP-690,550 as Maintenance Therapy in Patients with Crohn's Disease

  De Villiers, W.

  6/29/12 → 6/29/14

  Project: Research project

• A 3-Month, Multicenter, Double-Masked, Randomized, Parallel, Vehicle-Controlled Study of the Efficacy and Safety of 0.2% Brimonidine-Purite Opthalmic Solution for the Treatment of Acute Non-Arteritic Anterior Ischemic Optic Neuropathy

  Baker, R.

  7/1/00 → 6/30/01

  Project: Research project

• A45 Clinical Trial Agreement: Combination Anti-Amyloid Therapy for Preclinical Alzheimer's Disease

  Jicha, G.

  University of Southern California

  9/30/19 → 5/31/23

  Project: Research project

• A4 Study - Anti-Amyloid Treatment in Asymptomatic Alzheimer#s Disease: ADC-040-A4 (Lilly # H8A-MC-LZAZ)

  Jicha, G., Caban-Holt, A., Murphy, R. & Smith, C.

  University of California San Diego Health

  12/31/12 → 2/29/16

  Project: Research project

• A 4-Week, Dose Ranging Double-Blinded Randomized Placebo-controlled, Parallel group study to assess the Safety and Efficacy of ADP356 in Obese Patients

  Anderson, J. & Reynolds, L.

  1/1/05 → 12/31/06

  Project: Research project

• A 4-Week, Multicenter, Double-Blind, Randomized, Parallel Group Study to Compare the Gastrointestinal Safety and Tolerability of myfortic and MMF (Cellcept) When Administered in Combination with Calcineurin Inhibitors in Renal Transplant Recipients

  Waid, T.

  6/20/07 → 1/31/09

  Project: Research project

• A 52-week, Double-Blind, Randomized, Placebo Controlled Parallel Group Study to Evaluate the Effect of Roflumilast 500 #g on Exacerbation Rate in Subjects with Chronic Obstructive Pulmonary Disease (COPD) Treated with a Fixed Dose Combination of Long-Acti

  Mannino, D.

  4/19/12 → 6/30/13

  Project: Research project

• A 52-Week, Open-Label, Single-Arm Study to Evaluate the Safety and Tolerability of 24-Hour Daily Exposure of Continuous Subcutaneous Infusion of ABBV-951 in Subjects with Parkinson's Disease

  Slevin, J.

  AbbVie Incorporated

  5/1/19 → 6/14/21

  Project: Research project

• A 52 Week Randomized, Controlled, Open Label, Multicenter, Multinational, Parallel, Treat to Target Trial Comparing Efficacy and Safety of SIBA and Insulin Glargine Both Administered Once Daily

  Karounos, D.

  Novo Nordisk Pharmaceuticals Inc

  9/1/09 → 8/31/11

  Project: Research project

• A5332: Randomized Trial to Prevent Vascular Events in HIV - REPRIEVE

  Thornton, A.

  Massachusetts General Hospital

  5/1/15 → 4/30/23

  Project: Research project

• A5332: Randomized Trial to Prevent Vascular Events in HIV- REPRIEVE

  Thornton, A.

  Brigham and Women’s Hospital

  5/1/15 → 4/30/18

  Project: Research project

• A 5-Week, Randomized, Double-Blind, Placebo-Controlled, Multi-Dose Safety, Tolerance & Pharmacokinetics Study of CI-1034 in Patients with Secondary Pulmonary Hypertension Associated with Cardiopumnary Disease

  ABRAHAM, W. & LAMBA, S.

  6/15/01 → 10/3/02

  Project: Research project

• A 6 Day, Phase 3, Multicenter, Randomized, Double-Masked, Parallel Study to Compare the Safety and Efficacy of Gatifloxacin 0.5% Ophthalmic Solution BID with that of Vehicle in the Treatment of Acute Bacterial Conjunctivitis

  Capoor, S.

  Allergan Pharmaceuticals Inc

  10/1/08 → 12/31/08

  Project: Research project

• A 6-month safety and benefit study of Inhaled Fluticasone Propionate/Salmeterol Combination versus Inhaled Fluticasone Propionate in the Treatment of 6200 Pediatric Subjects 4-11 years old with Persistent Asthma

  Miller, B.

  Parexel International Co

  12/24/12 → 6/30/14

  Project: Research project